종근당 is involved in the pharmaceutical and healthcare sector, providing a range of products and services to enhance health and wellness.

Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc.; and healthcare supplements with preventive benefits. The company also exports its products. Chong Kun Dang pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.

1857

COM:CKDPHARM

종근당

Last Close

101.60K

12/11 06:30

Market Cap

1.36T

Beta: -

locale

market

industry

website

ipo date

competitor of

Metrics